About us│Overview & History

Home

CHA Advanced Research Institute CHA Advanced Research Institute

CHA Advanced Research Institute (CARI) was founded in 2018 by CHA Group,
Korea's first and only industry-academic research-medical infrastructure.
CARI's mission as a translational research organization
is to find medical solutions to improve human health and welfare.

연구원 이미지

CHA Advanced Research Institute CHA Advanced Research Institute

CARI promotes commercialization by
coordinating and integrating the entire R&D landscape

Cell and Gene Therapy
(CGT)
Novel therapeutic
candidate identification
External research collaboration
Technology Commercializaition

CHA Advanced Research Institute

CARI harbors twelve research units for developing
CGTs, pharmaceuticals, and consumer health products.
R&D support centers facilitate in vitro & in vivo preclinical R&D programs

Furthermore, CARI is trying to become a global leader
in CGT R&D platform development for rare, incurable diseases by
utilizing Cha Group's domestic and foreign medical networks and clusters by cooperating closely with Cell TheP, a cell therapy development support platform at the Bundang Cha Medical Center.

CHA Advanced Research Institute: CARI will make every effort to contribute to finding a solution
to the unmet medical needs with seminal research findings
and novel medical technologies, ultimately making all humanity healthier.

ADVANCED RESEARCH INSTITUTE

Overview & History